ResearcherCatholic University of KoreaNo recent work listed
Ja Hee Suh
Matched on ORCID iD 0000-0003-1423-2139; OpenAlex author ID A5103093936, A5157802697. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2021: 1 paper · 2022: none · 2023: 1 paper
Papers 2
- Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overexpression. Last author DOI 10.3390/jcm12165394↗
- Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a r… Co-author DOI 10.1186/s12885-021-08887-1↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Myung Ah Lee · 2 shared papers, 2021–2023 · strength 0.36
- Paper Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overex… DOI 10.3390/jcm12165394↗
- Paper Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastat… DOI 10.1186/s12885-021-08887-1↗
- Kabsoo Shin · 2 shared papers, 2021–2023 · strength 0.36
- Paper Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overex… DOI 10.3390/jcm12165394↗
- Paper Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastat… DOI 10.1186/s12885-021-08887-1↗
- Tae Ho Hong · 2 shared papers, 2021–2023 · strength 0.36
- Paper Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overex… DOI 10.3390/jcm12165394↗
- Paper Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastat… DOI 10.1186/s12885-021-08887-1↗
- Se Jun Park · 2 shared papers, 2021–2023 · strength 0.36
- Paper Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overex… DOI 10.3390/jcm12165394↗
- Paper Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastat… DOI 10.1186/s12885-021-08887-1↗
- In-Ho Kim · 1 shared paper, 2023 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.